BioSpace News Archive

Medtronic Expands Diabetes Support Programs to Help Customers Losing Insurance Coverage Due to Job Loss as a Result of COVID-19

Medtronic Assurance Program Will Provide Access to Glucose Sensors and Insulin Pump Supplies at No Cost to Eligible U.S. Customers

May 6, 2020
·
3 min read
COVID-19 Insights: Quantzig’s Latest Success Story Illustrates How Supply Chain Analytics Solutions Can Help Healthcare Companies Curtail Risks Associated with the Supply of Products

Quantzig, global data analytics and advisory firm, that delivers actionable analytics solutions presents a new case study series that focuses on how coronavirus is impacting businesses across geographies.

May 6, 2020
·
5 min read
Genetown

Activ Surgical Introduces New Surgical Intelligence and Sensing Platform to Revolutionize Surgery

Activ Surgical, a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, today announced its ActivEdge platform

May 6, 2020
·
5 min read
Business

AIkido Pharma Executes Artificial Intelligence and Machine Learning Research Agreement with Cogia Biotech LTD

AIkido Pharma Inc. (Nasdaq: AIKI) today announced execution of an Artificial Intelligence (AI), and Machine Learning (ML) research agreement with Cogia Biotech LTD (“Cogia”) (www.cogia.de) to accelerate the Company’s pancreatic cancer genetic marker research.

May 6, 2020
·
4 min read
FDA

Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14

Tabrecta (capmatinib, formerly INC280) is the first and only therapy approved by the FDA to specifically target metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14)(1)

May 6, 2020
·
14 min read
FDA

Foundation Medicine Receives FDA Approval for FoundationOne®CDx as the Companion Diagnostic for Tabrecta™ (capmatinib), the Only FDA-Approved MET Inhibitor for Patients With Metastatic Non-Small Cell Lung Cancer With METex14

Foundation Medicine, Inc. announced that FoundationOne®CDx has been approved by the U.S. Food and Drug Administration for use as the companion diagnostic to aid in identifying patients with non-small cell lung cancer for whom treatment with Tabrecta™ may be appropriate.

May 6, 2020
·
4 min read
Deals

LifeSci Acquisition Corp. Announces that Common Stock and Warrants Commenced Separate Trading

LifeSci Acquisition Corp. announced that holders of the Company’s units may elect to separately trade the ordinary shares and warrants included in its units.

May 6, 2020
·
1 min read
Business

Livongo Reports First Quarter 2020 Financial Results

Livongo Health, Inc., the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, announced financial results for its first quarter ended March 31, 2020.

May 6, 2020
·
13 min read
Business

TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020

TRACON Pharmaceuticals announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Wednesday, May 13, 2020.

May 6, 2020
·
1 min read
Business

Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results

Pacific Biosciences of California, Inc. announced financial results for its first quarter ended March 31, 2020.

May 6, 2020
·
6 min read